Annual Drug Patent Expirations for TOSYMRA
Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. It is available from two suppliers. There are seven patents protecting this drug.
This drug has seventy-one patent family members in twenty-one countries.
The generic ingredient in TOSYMRA is sumatriptan. Two suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com